Mild Behavioral Impairment and Quality of Life in Community Dwelling Older Adults
- PMID: 39349389
- DOI: 10.1002/gps.6153
Mild Behavioral Impairment and Quality of Life in Community Dwelling Older Adults
Abstract
Objectives: Mild behavioral impairment (MBI) is a dementia risk indicator in older adults characterized by later-life emergent and persistent neuropsychiatric symptoms. Quality of life (QoL) is a multi-dimensional concept encompassing physical, spiritual, and emotional well-being. QoL aims to measure and quantify perceptions of individual health, well-being, standard of living, personal fulfillment, and satisfaction. As MBI symptoms may arise from early-stage neurodegenerative disease, MBI may contribute to declining QoL before dementia onset. In this study, we investigated the relationship between symptoms of MBI and QoL in older adults.
Methods: The sample comprised 1107 individuals aged ≥ 50 years from the Canadian Platform for Research Online to Investigate Health, Quality of Life, Cognition, Behavior, Function, and Caregiving in Aging (CAN-PROTECT). Multivariable linear regressions were used to model the associations between MBI symptom severity (exposure), measured using the MBI Checklist (MBI-C), and QoL (outcome) assessed by the EuroQol-5D (EQ-5D, higher score = poorer QoL) and the novel Quality of Life and Function Five Domain Scale (QFS-5) (QFS-5, lower score = poorer QoL). Covariates were age, sex, cognition, education, ethnocultural origin, marital status, employment status, high blood pressure, heart disease, and diabetes. Moderation analysis explored potential sex differences. A sensitivity analysis was performed removing anxiety/depression items from the EQ-5D score.
Results: Across the sample (mean age = 64.4 ± 7.2, 79.4% female) every 1-point increase in MBI-C score was associated with a 0.06-point standard deviation (SD) increase in EQ-5D score (95% confidence interval (CI): 0.05-0.06, p < 0.001) and 0.08 SD decrease in QFS-5 score (95% CI: -0.09 to -0.08, p < 0.001). Neither association depended on sex (p = 0.59 and p = 0.41, respectively). The association remained significant after removing anxiety/depression items from the EQ-5D score (β = 0.04, 95% CI: 0.03- 0.04, p < 0.001).
Conclusions: The study shows that MBI is associated with poorer QoL, independent of sex, on two QoL scales. We addressed depression/anxiety items in the EQ-5D as a potential confounder for the observed MBI-QoL association by conducting a sensitivity analysis that excluded those items from the EQ-5D total score and by employing a novel measure of QoL (QFS-5) that excludes psychiatric symptoms from measurement of QoL. Associations of MBI with the novel QFS-5 were similar to associations between MBI and the EQ-5D. Finding interventions to reduce the burden of MBI symptoms might improve quality of life.
Keywords: EQ‐5D; QFS‐5; aging; behavior; cognition; dementia; life engagement; mild behavioral impairment (MBI); quality of life (QoL).
© 2024 The Author(s). International Journal of Geriatric Psychiatry published by John Wiley & Sons Ltd.
References
-
- M. Prince, A. Wimo, M. Guerchet, G.‐C. Ali, Y.‐T. Wu, and M. Prina, World Alzheimer Report 2015. The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends (London: Alzheimer's Disease International, 2015).
-
- M. H. Connors, K. Seeher, A. Teixeira‐Pinto, M. Woodward, D. Ames, and H. Brodaty, “Dementia and Caregiver Burden: A Three‐Year Longitudinal Study,” International Journal of Geriatric Psychiatry 35, no. 2 (2020): 250–258, https://doi.org/10.1002/gps.5244.
-
- P. Antuono and J. Beyer, “The Burden of Dementia: A Medical and Research Perspective,” Theoretical Medicine and Bioethics 20, no. 1 (1999): 3–13, https://doi.org/10.1023/a:1009915605467.
-
- W. Moon, J. W. Han, J. B. Bae, et al., “Disease Burdens of Alzheimer's Disease, Vascular Dementia, and Mild Cognitive Impairment,” Journal of the American Medical Directors Association 22, no. 10 (2021): 2093–2099, https://doi.org/10.1016/j.jamda.2021.05.040.
-
- B. Dubois, H. Hampel, H. H. Feldman, et al., “Preclinical Alzheimer's Disease: Definition, Natural History, and Diagnostic Criteria,” Alzheimer's and Dementia 12, no. 3 (2016): 292–323, https://doi.org/10.1016/j.jalz.2016.02.002.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials